254
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Clinical Significance of Long Non-Coding RNA SNHG5 in the Diagnosis and Prognosis of Chronic Obstructive Pulmonary Disease

, , &
Article: 2363630 | Received 25 Jan 2024, Accepted 29 May 2024, Published online: 08 Jul 2024

References

  • Yu C, Zhang L. Methylprednisolone up-regulates annexin A1 (ANXA1) to inhibit the inflammation, apoptosis and oxidative stress of cigarette smoke extract (CSE)-induced bronchial epithelial cells, a chronic obstructive pulmonary disease in vitro model, through the formyl peptide receptor 2 (FPR2) receptors and the adenosine 5’-monophosphate (AMP)-activated protein kinase (AMPK) pathway. Bioengineered. 2022;13(2):1–9. doi: 10.1080/21655979.2022.2031769.
  • Alupo P, Wosu AC, Mahofa A, et al. Incidence and predictors of COPD mortality in Uganda: a 2-year prospective cohort study. PLoS One. 2021;16(2):e0246850. doi: 10.1371/journal.pone.0246850.
  • Xu Z, Zhu L, Zhan J, et al. The efficacy and safety of high-flow nasal cannula therapy in patients with COPD and type II respiratory failure: a meta-analysis and systematic review. Eur J Med Res. 2021;26(1):122. doi: 10.1186/s40001-021-00587-7.
  • Skurikhin E, Pershina O, Zhukova M, et al. Spiperone stimulates regeneration in pulmonary endothelium damaged by cigarette smoke and lipopolysaccharide. Int J Chron Obstruct Pulmon Dis. 2021;16:3575–3591. doi: 10.2147/COPD.S336410.
  • Hoult G, Gillespie D, Wilkinson TMA, et al. Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis. BMC Pulm Med. 2022;22(1):194. doi: 10.1186/s12890-022-01958-4.
  • Furci F, Murdaca G, Pelaia C, et al. TSLP and HMGB1: inflammatory targets and potential biomarkers for precision medicine in asthma and COPD. Biomedicines. 2023;11(2):437. doi: 10.3390/biomedicines11020437.
  • Zheng PF, Chen LZ, Liu P, et al. A novel lncRNA-miRNA-mRNA triple network identifies lncRNA XIST as a biomarker for acute myocardial infarction. Aging (Albany NY). 2022;14(9):4085–4106. doi: 10.18632/aging.204075.
  • Han T, Liao A. CASC7: a LncRNA with potential clinical application. Int J Radiat Biol. 2022;98(10):1510–1518.
  • Xu X, Liang Y, Gareev I, et al. LncRNA as potential biomarker and therapeutic target in glioma. Mol Biol Rep. 2023;50(1):841–851. doi: 10.1007/s11033-022-08056-y.
  • Tang W, Shen Z, Guo J, et al. Screening of long non-coding RNA and TUG1 inhibits proliferation with TGF-beta induction in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2951–2964. doi: 10.2147/COPD.S109570.
  • Shen Q, Zheng J, Wang X, et al. LncRNA SNHG5 regulates cell apoptosis and inflammation by miR-132/PTEN axis in COPD. Biomed Pharmacother. 2020;126:110016. doi: 10.1016/j.biopha.2020.110016.
  • Neumeier A, Keith R. Clinical guideline highlights for the hospitalist: the GOLD and NICE guidelines for the management of COPD. J Hosp Med. 2020;15(4):240–241. doi: 10.12788/jhm.3368.
  • Şerifoğlu İ, Ulubay G. The methods other than spirometry in the early diagnosis of COPD. Tuberk Toraks. 2019;67(1):63–70. doi: 10.5578/tt.68162.
  • Fazleen A, Wilkinson T. Early COPD: current evidence for diagnosis and management. Ther Adv Respir Dis. 2020;14:1753466620942128. doi: 10.1177/1753466620942128.
  • Xie J, Wu Y, Tao Q, et al. The role of lncRNA in the pathogenesis of chronic obstructive pulmonary disease. Heliyon. 2023;9(11):e22460. doi: 10.1016/j.heliyon.2023.e22460.
  • Zong D, Liu X, Li J, et al. LncRNA-CCAT1/miR-152-3p is involved in CSE-induced inflammation in HBE cells via regulating ERK signaling pathway. Int Immunopharmacol. 2022;109:108818. doi: 10.1016/j.intimp.2022.108818.
  • Wang J, Zhang Y, Zhang L. Long non-coding RNA SNHG5 suppresses the development of acute respiratory distress syndrome by targeting miR-205/COMMD1 axis. Mol Cell Biochem. 2021;476(2):1063–1074. doi: 10.1007/s11010-020-03972-8.
  • Wang Y, Xu J, Meng Y, et al. Role of inflammatory cells in airway remodeling in COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:3341–3348. doi: 10.2147/COPD.S176122.
  • Guo P, Li R, Piao TH, et al. Pathological mechanism and targeted drugs of COPD. Int J Chron Obstruct Pulmon Dis. 2022;17:1565–1575. doi: 10.2147/COPD.S366126.
  • Li H, Xuan J, Zhang W, et al. Long non-coding RNA SNHG5 regulates ulcerative colitis via microRNA-375/Janus kinase-2 axis. Bioengineered. 2021;12(1):4150–4158. doi: 10.1080/21655979.2021.1953219.
  • Grubek-Jaworska H, Paplinska M, Hermanowicz-Salamon J, et al. IL-6 and IL-13 in induced sputum of COPD and asthma patients: correlation with respiratory tests. Respiration. 2012;84(2):101–107. doi: 10.1159/000334900.
  • Corsonello A, Pedone C, Battaglia S, et al. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) as inflammation markers in elderly patients with stable chronic obstructive pulmonary disease (COPD). Arch Gerontol Geriatr. 2011;53(2):190–195. doi: 10.1016/j.archger.2010.10.015.
  • Mosrane Y, Bougrida M, Alloui AS, et al. [Systemic inflammatory profile of smokers with and without COPD]. Rev Pneumol Clin. 2017;73(4):188–198. doi: 10.1016/j.pneumo.2017.07.003.
  • Shu B, Li H, Zhou X, et al. Efficacy and safety of Re Du ning injection for acute exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2022;2022:7479639–7479610. doi: 10.1155/2022/7479639.
  • Peltola L, Pätsi H, Harju T. COPD comorbidities predict high mortality - asthma-COPD-overlap has better prognosis. COPD. 2020;17(4):366–372. doi: 10.1080/15412555.2020.1783647.